TrialHeadache2021

Phase 2 randomized placebo-controlled study of lasmiditan for the acute treatment of migraine in Japanese patients.

Fumihiko Sakai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.